a,b, Fluorescence in
situ hybridization (using the RNAscope kit) demonstrates high
co-localization of Drd1 and Esr1
expression in the MPOA (a), with an average of ~2 Drd1 puncta per
Esr1 cell (n = 3 mice). The masks were selected based on
Esr1 puncta. A cropped subregion of these images is
shown in Fig. 4f. Scale bars: 100
μm.
c, In the LPOA, 39% of the Esr1 neurons also express
Drd1 (average ~2 Drd1 puncta
per Esr1 cell), and 68% of the Drd1 puncta are found in the
Esr1 cells.
d, Sample field of view of cADDis expression in the
Esr1 neurons in the MPOA (defined as the subregion of the preoptic area
within 600 μm from the midline) and the LPOA (defined as the
subregion beyond 600 μm from the midline). The definition of the
boundary at 600 μm is derived from a standard mouse atlas62. Experimental designs are
replotted here. In Experiment 1, we first used a concentric bipolar
electrode to locally stimulate the AVPV/PVpo area for 20 rounds (20 Hz
trains, 75 μA pulses for 1 s every 20 s) and then washed on the D1/D5
agonist SKF81297 (2 μM; diluted from 100 mM stock solution in
dimethyl sulfoxide). In Experiment 2, we first used a minimal stimulation
protocol to identify the MPOA Esr1 neurons that responded to AVPV/PVpo
stimulations, washed on the D1/D5 antagonist SCH23390 (300 nM; diluted from
50 mM stock solution in saline), and then performed 20 more rounds of
AVPV/PVpo stimulation in the presence of the antagonist.
e, Heatmaps showing the cell-by-cell cADDis response
in the MPOA to both AVPV/PVpo stimulation (left) and D1/D5 agonist wash-on
(right). Stimulation responses are averages of 20 trials, following baseline
subtraction of the pre-stimulation means, while the agonist response is a
single-trial response following baseline subtraction of the pre-agonist
value. Esr1 neurons are divided into those that responded to the agonist
(above the horizontal blue line) and those that did not (below the
horizontal blue line) using a classifier (see Methods). Cells are sorted based on their agonist response and
the same order is used for both panels. Gray lines on the top denote the
windows that are used for quantification and classification. The color of
the ‘Slide ID’ indicates the identity of the slice (n = 983
neurons from 4 slices, 3 mice) from which the cell was recorded.
f,g, In the agonist-responsive group
(orange), neurons show persistent cAMP elevations (decreases in cADDis
intensity) that accumulate after each AVPV/PVpo stimulation
(f). The cAMP elevations are not seen in the
agonist-unresponsive group (gray in f; n = 4 slices from 3
males). Panel g summarizes agonist responses (n = 4 slices from
3 males).
h, Heatmaps showing the cell-by-cell cADDis response
of MPOA Esr1 neurons to AVPV/PVpo stimulation both before (left) and after
washing on the D1/D5 antagonist (right). Stimulation responses are averages
of 3 and 20 trials, following baseline subtraction of the pre-stimulation
means. MPOA Esr1 neurons are divided into those that responded to the
pre-antagonist stimulation (above the horizontal blue line) and those that
did not (below the horizontal blue line) using a classifier (see Methods). Cells are sorted based on their
stimulation response, and the same order is used for both panels. Gray lines
on the top denote the windows that are used for quantification and
classification. The color of the ‘Slide ID’ indicates the
identity of the slice (n = 947 cells from 4 slices, 3 mice) from which the
cell was recorded.
i,j, In the stimulation-responsive group
(red), neurons show persistent cAMP elevations that are accumulated after
each AVPV/PVpo stimulation (i: n = 4 slices from 3 males). The
cAMP elevations are not seen after the antagonist wash-on (j: n
= 4 slices from 3 males).
k, Same as e but for LPOA Esr1 neurons (n
= 192 cells from 4 slices, 3 mice).
l,m, Same as
f-g but for LPOA neurons. Note that LPOA Esr1
neurons (including those in the agonist-responsive group) did not respond to
AVPV/PVpo stimulation (n = 4 slices from 3 males).
n,o, Same as
l-m but for fluorescence lifetime measurements
(a bleaching-insensitive way of analyzing fluorescence data; see Methods). Note that LPOA Esr1 neurons did
not respond to AVPV/PVpo stimulation, including those in the
agonist-responsive group (n = 4 slices from 3 males).
p-r, In Experiment 2, we again observed
only very few AVPV/PVpo stimulation-responsive neurons in the LPOA, before
or after antagonist application (n = 198 cells from 4 slices, 3 mice).
Plotting conventions are the same as above. Note that we did not plot
average responses of the stimulation-responsive group due to its small
size.
s,t, In combined data from Experiments 1
and 2, the fraction of cells that responded to AVPV/PVpo stimulation
gradually dropped off over distance from the midline (t; n =
2320 cells from 8 slices, 6 mice). Axon fields of AVPV/PVpo dopamine neurons
shown here for comparison (s). Scale bars: 200 μm.
u, In the agonist-responsive group (orange), MPOA Esr1
neurons show persistent elevations in PKA activity (decreases in FLIM-AKAR
lifetime) that accumulate across repeated trials of AVPV/PVpo stimulation.
The cAMP elevations are not seen in the agonist-unresponsive group (gray; n
= 4 slices from 3 males). The right panel summarizes agonist responses (n =
4 slices from 3 males).
v, In the stimulation-responsive group (red), MPOA
Esr1 neurons show persistent elevations in PKA activity that accumulate
after each AVPV/PVpo stimulation (left: n = 4 slices from 3 males). The
elevations in PKA activity are not seen after antagonist wash-on (right: n =
4 slices from 3 males).
w, Same as u but for LPOA Esr1 neurons.
Note that LPOA Esr1 neurons did not respond to AVPV/PVpo stimulation,
including those in the agonist-responsive group (n = 4 slices from 3
males).
x, In Experiment 2, we again only recorded very few
numbers of AVPV/PVpo stimulation-responsive Esr1 neurons in the LPOA, before
or after antagonist. See above for plotting conventions. Note that we did
not plot average responses of the stimulation-responsive group due to its
small size.
Mean ± s.e.m. *p<0.05, **p<0.01,
***p<0.001. See Supplementary Table 1 for statistics.